- Accueil >
- Publications >
- Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring ALK Y1278S Mutation
Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring ALK Y1278S Mutation
Auteurs
Antoine Vasseur, Luc Cabel, Romain Geiss, Gudrun Schleiermacher, Gaëlle Pierron, Maud Kamal, Nina Jehanno, Guillaume Bataillon, Jean-Marc Guinebretiere, Laurence Bozec